Overview
This is a multicenter, prospective study aimed at providing information on the psychological effects (including post-traumatic stress symptoms) of utero-vaginal brachytherapy in patients with cervical cancer using self-administered questionnaires. The study also aims to assess the persistence of these symptoms over time, up to 5 years after brachytherapy. The results could help identify patients at risk of post-traumatic stress in this context and develop appropriate psychological interventions to improve their psychological well-being during and after treatment.
Eligibility
Inclusion Criteria:
- Confirmed diagnosis of cervical cancer with an indication for High-dose rate (HDR) or pulse-dose rate (PDR) uterovaginal brachytherapy;
- Squamous cell carcinoma or other histological types;
- WHO ≤ 2;
- Ability to complete validated questionnaires in French;
- Informed consent to participate in the study;
- Patients over 18 years old
Exclusion Criteria:
- Inability to understand or respond to questionnaires due to a cognitive disorder, intellectual disability, language barrier, or psychiatric disorder that impairs judgment;
- Patient under juridic protection;
- Pregnant or breastfeeding woman
